syngene videos
-
Elevate Your Protein Production With SynWeave™
6/15/2026
Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.
-
Integrated DS-DP Manufacturing For Your Biologics
6/15/2026
Discover how next-generation biologics manufacturing can help accelerate your path from molecule to market with the scale, speed, and flexibility needed to support your program at every stage.
-
Biologics DS Manufacturing Facility Across The U.S. And India
6/15/2026
Our integrated setup enables seamless progression from early-stage development to commercial production, providing flexibility, scalability, and operational efficiency to accelerate biologics programs and support evolving market demands.
-
Biologics DP Manufacturing Facility — 1M Vials Per Day
6/15/2026
Our facility features two high-speed vial filling lines capable of producing up to one million vials per day, accommodating fill volumes ranging from 1 mL to 100 mL across a broad range of biologic products.
-
India's Only GLP-Certified Viral Testing Facility
6/3/2026
Get an overview of a GLP-certified viral testing facility that delivers comprehensive safety solutions, collaborative research support, and viral clearance data for biologics processes.
-
What Can Our Global CRO/CDMO Services Do For You?
6/3/2026
Explore the state-of-the-art multi-product, multi-client contract manufacturing facility that could serve as your one-stop shop for drug discovery, development, and manufacturing needs.
-
Advancing Science Together A With State-Of-The-Art Analytical Facility
6/1/2026
Our team provides method development, validation, and testing services, ensuring quality and regulatory compliance across drug discovery and manufacturing processes.
-
Sterile Fill-Finish Facility
5/26/2026
See key steps in biologics production or cell line development, highlighting challenges, optimization strategies, and methods used to improve consistency, productivity, and scalability.